USC Dornsife News

Physicist Peter Kuhn aims to give patients the power to work with physicians to ensure the best possible treatment outcomes for their individual disease.

Using nano-probes to amplify biochemical signals could lead to targeted, noninvasive treatment of cancer.

USC Michelson Center scientists use metal-tagged markers and a patient's blood sample, aiming for precise treatments of cancerous cells that spread to other organs.

Why are middle-aged white Americans dying at increasing rates? Nobel Prize–winning economist Angus Deaton has uncovered startling data that show mortality numbers are climbing for this group. How can we buck the trend?

USC Michelson Center scientists are part of an international team developing new alternatives to easing pain in the midst of a national crisis.

Dion Dickman of biological sciences is studying the way nerve cells maintain normal levels of communication, giving insight into how neuropsychiatric diseases arise — and might be treated.

The USC Iovine and Young Academy builds on convergent bioscience efforts with USC Dornsife’s Peter Kuhn to begin work on a new track for students aimed at helping patients participate in their own care.

Alumna Sarah Urke, who suffered a serious concussion as a competitive synchronized swimmer, aims to broaden knowledge of how to prevent and respond to brain injuries.

Mork Family Scholar is revolutionizing how discarded fruit and vegetable pulp from trendy juiceries is used, turning the formerly trashed waste into healthy, high-fiber foods.